Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ Alphavirus infection medication

Viral Encephalomyelitis – Recovery from Encephalitis Results in Virus Persistence and the Need for Long-Term Immune Control

Alphavirus-Based Vaccines – 7. Conclusions

Replicon RNA Viral Vectors as Vaccines – 3.3. Clinical Trials

Alphavirus-Based Vaccines – 4. Tumor Vaccine Approaches

Self-Replicating RNA Viruses for RNA Therapeutics – 5. Conclusions and Future Aspects

Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development – Bottlenecks for chikungunya vaccine development: Which obstacles should be removed?

Viral Encephalomyelitis – Conclusions

Detection of central nervous system viral infections in adults in Manado, North Sulawesi, Indonesia – Conclusions

Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development – Conclusion

Recent vaccine technology in industrial animals – Conclusion

Self-Replicating RNA Viruses for RNA Therapeutics – 4. Clinical Trials

Detection of central nervous system viral infections in adults in Manado, North Sulawesi, Indonesia – Results

Replicon RNA Viral Vectors as Vaccines – 4. Conclusions

A Field-Deployable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of the Chikungunya Virus – Ethical Statement Clinical Samples

Recent vaccine technology in industrial animals – RNA Particle Vaccine for Porcine Epidemic Diarrhea

Identification of a novel Getah virus by Virus-Discovery-cDNA random amplified polymorphic DNA (RAPD) – Background

Protective immunity by an engineered DNA vaccine for Mayaro virus – Cell culture

Validation of the easyscreen flavivirus dengue alphavirus detection kit based on 3base amplification technology and its application to the 2016/17 Vanuatu dengue outbreak – Statistical analysis

A Field-Deployable Reverse Transcription Recombinase Polymerase Amplification Assay for Rapid Detection of the Chikungunya Virus – Discussion

Validation of the easyscreen flavivirus dengue alphavirus detection kit based on 3base amplification technology and its application to the 2016/17 Vanuatu dengue outbreak – Clinical samples

Protective immunity by an engineered DNA vaccine for Mayaro virus – Discussion

Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV) – Detection of VEEV antigen in lysates of infected Vero cells

Peptide inhibitors of dengue virus and West Nile virus infectivity – Design and synthesis of peptides

Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform – Ethics statement.

Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV) – Conclusion